Lipodystrophy among HIV-Infected Patients Attending Care and Treatment Clinics in Dar es Salaam

Table 1

Sociodemographic and general characteristics of the study participants.

Characteristic	Number (%)
Age (years)
≤30 years	51 (10.9)
31–40 years	194 (41.6)
41–50 years	134 (28.8)
≥51 years	67 (14.4)
Missing	20 (4.3)
Gender
Male	117 (25.1)
Female	349 (74.9)
Marital status
Married	219 (47.0)
Single	89 (19.1)
Divorced/separated	81 (17.4)
Widowed	77 (16.5)
Education level
No formal education	27 (5.8)
Primary education	356 (76.4)
Secondary education	68 (14.6)
College/university	15 (3.2)
CTC of enrolment
Amana Hospital	152 (32.6)
Temeke Hospital	155 (33.3)
Mwananyamala Hospital	159 (34.1)
HAART use
On HAART	238 (51.1)
HAART naïve	228 (48.9)
Type of HAART
Nevirapine based regimen	31 (13.0)
Efavirenz based regimen	118 (49.6)
Stavudine based regimen	86 (36.1)
Protease Inhibitor based regimen	3 (1.3)
Duration of HAART use
HAART naïve	228 (48.9)
24 months	60 (12.9)
25–48 months	149 (32.0)
>48 months	29 (6.2)
Lipodystrophy
Yes	95 (20.4)
No	371 (79.6)
Types of lipodystrophy
Primary lipoatrophy	47 (49.5)
Primary lipohypertrophy	12 (12.6)
Mixed lipodystrophy	36 (37.9)
Body Mass Index (BMI)
Underweight	58 (12.5)
Normal weight	235 (50.5)
Overweight	110 (23.7)
Obese	62 (13.3)
Central obesity
No	301 (64.7)
Yes	164 (35.7)

BMI: Body Mass Index; CTC: Care and Treatment Clinic; HAART: Highly Active Antiretroviral Therapy.